Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors

Completed · Phase 1

Conditions studied: Melanoma (Skin), Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Interferon gamma may interfere with the growth of cancer cells and may be an effective treatment for melanoma and solid tumors. PURPOSE: Phase I trial to study the effectiveness of interferon gamma in treating patients with recurrent or metastatic melanoma or other solid tumors.

Key facts

Study ID

NCT00004016

Run by

University of Rochester

Starts

1999-04-01

Last updated by the study team

2013-06-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Rochester Cancer Center — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.